Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001144204-19-047722

10% owner bought 400,000 shares at $15.00 ($6,000,000)

  • 10% owner acquired 1,868,718 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Redmile Group, LLC 10% owner 2019-10-07 Conversion +1,868,718 1,868,718 I
Redmile Group, LLC 10% owner 2019-10-07 Purchase +400,000 $15.00 $6,000,000 2,268,718 I
Derivatives
Redmile Group, LLC 10% owner 2019-10-07 Conversion · Series C Preferred Stock −1,164,674 0 I
Open-market purchases · 400,000 sh · avg $15.00 · $6,000,000
Loading xslF345X03/tv530719_4.xml…